Delivery Order SPE2DB22D1202-SPE2DB25FUZY2
Award Date
5/14/25
Potential Completion Date
5/15/25
Potential Value
$55K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a medical product, with an ultimate completion date of May 15, 2025 and a ceiling value of $3,910.45. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a $11,238.10 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, which is a specialized medication. The contract has an ultimate completion date of March 19, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication, with a ceiling value of $3,149.12 and a period of performance through March 31, 2025. The contract is a Firm Fixed Price delivery order and does not have a set-aside designation, indicating open...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, with a ceiling value of $6,717.96 and a performance period ending on April 18, 2025. The contract is a firm fixed-price, non-set-aside award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $26,144.38, is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The contract has an ultimate completion date of March 14, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $15,133.64 and a completion date of May 15, 2025. The contract is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,574.56, is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The award has an ultimate completion date of February 18, 2025 and is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $3,976.49, is for the provision of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product. The contract has an ultimate completion date of April 23, 2025 and was awarded on April 22, 2025. This contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen...
This is a firm-fixed-price delivery order (contract) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,298.24, is for the supply of COSENTYX UNOREADY 300 MG PEN 2ML, a specialty medication. The contract has an ultimate completion date of March 6, 2025. AmerisourceBergen is the prime contractor for this award and holds a larger Indefinite Delivery Contract (IDC) with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,547.07 contract is for the supply of 4567953352 COSENTYX UNOREADY 300 MG PEN 2ML, a prescription medication. The contract has an ultimate completion date of April 18, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. This award is not...